RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VALVANO MR
Collezione AOU Città della Salute di Torino

Items : 4

Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. in European journal of internal medicine / Eur J Intern Med. 2018 Jul;53:79-84. doi: 10.1016/j.ejim.2018.02.015. Epub 2018 Feb 21.

2018
AOU Città della Salute di Torino

Martini S; Petrini E; Russello M; Smedile A; Coco C; Brancaccio G; Grossi A; Ippolito AM; Valvano MR; Grattagliano I; Mariano A; Stroffolini T; Andriulli A; Gaeta GB; Rizzetto M; Andriulli A; Stroffolini T; Mariano A; Valvano MR; Grattagliano I; Ippolito AM; Grossi A; Brancaccio G; Coco C; Russello M; Smedile A; Petrini E; Martini S; Gaeta GB; et alii...

HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Sep;49(9):1022-1028. doi: 10.1016/j.dld.2017.03.025. Epub 2017 Apr 8.

2017
AOU Città della Salute di Torino

Ippolito AM; Milella M; Messina V; Conti F; Cozzolongo R; Morisco F; Brancaccio G; Barone M; Santantonio T; Masetti C; Tundo P; Smedile A; Carretta V; Gatti P; Termite AP; Valvano MR; Bruno G; Fabrizio C; Andreone P; Zappimbulso M; Gaeta GB; Napoli N; Fontanella L; Lauletta G; Cuccorese G; Metrangolo A; Francavilla R; Ciracì E; Rizzo S; et alii...

HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2016 Sep;44(6):620-8. doi: 10.1111/apt.13734. Epub 2016 Jul 22.

2016
AOU Città della Salute di Torino

Niro GA; Smedile A; Fontana R; Olivero A; Ciancio A; Valvano MR; Pittaluga F; Coppola N; Wedemeyer H; Zachou K; Marrone A; Fasano M; Lotti G; Andreone P; Iacobellis A; Andriulli A; Rizzetto M;

Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin. in Journal of hepatology / J Hepatol. 2014 Jan;60(1):16-21. doi: 10.1016/j.jhep.2013.07.040. Epub 2013 Aug 20.

2014
AOU Città della Salute di Torino

Andriulli A; Di Marco V; Margaglione M; Ippolito AM; Fattovich G; Smedile A; Valvano MR; Calvaruso V; Gioffreda D; Milella M; Morisco F; Felder M; Brancaccio G; Fasano M; Gatti P; Tundo P; Barone M; Cozzolongo R; Angelico M; D'Andrea G; Andriulli N; Abate ML; Mazzella G; Gaeta GB; Craxi A; Santantonio T;